In vitro antifungal resistance of oral Candida albicans strains in non-AIDS patients

Oral Microbiology and Immunology

Volumn 12, Issue 2, 1997, Pages 126-128

  Monteil, R A ^a   Madinier, I ^a   Le Fichoux, Y ^b  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b University of Côte d'Azur   (France)

Author keywords

Antifungal agent; Candida albicans; In vitro susceptibility testing

Indexed keywords

EID: 0031126498     PISSN: 09020055     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-302X.1997.tb00629.x     Document Type: Article

References (22)

1. Baily GG, Perry FM, Denning DW, Mandal BK. Fluconazole-resistant candidosis in an HIV cohort. AIDS 1994: 8: 787-92.
2. Bissell V, Felix DH, Wray D. Comparative trial of fluconazole and amphotericin in the treatment of denture stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1993: 76: 35-9.
3. British Society for Antimicrobial Chemotherapy Working Party. Antifungal chemotherapy in patients with acquired immunodeficiency syndrome. Lancet 1992: 2: 648-51.
4. Cawson RA, Lehner T. Chronic hyperplastic candidiasis-candidal leukoplakia. Br J Dermatol 1968: 80: 9-16.
5. Chavanet P, Lopez J, Grappin M et al. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients. AIDS 1994: 8: 945-50.
6. Conly J, Rennie R, Johnson J, Farah S, Hellman L. Disseminated candidiasis due to amphotericin B-resistant Candida albicans. J Infect Dis 1992: 165: 761-4.
7. Fotos P, Vincent S, Hellstein J. Oral candidosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1992: 74: 41-9.
8. Garber E. Treatment of oral Candida mucositis infections. Drugs 1994: 47: 734-40.
9. Gari-Toussaint M, Delpech D, Pagliardini G, Le Fichoux Y. Adaptation de l'ATB-Fungus® à la détermination de la sensibilité des levures au fluconazole. In: Société Française de Mycologie Medicale, Institut Pasteur 1995; Paris 24-25 Nov; 26.
10. Goff DA, Koletar SL, Buesching WJ, Barnishan J, Fass RJ. Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles. Clin Infect Dis 1995: 20: 77-83.
11. Greenspan D. Treatment of oropharyngeal candidiasis in HIV-positive patients. J Am Acad Dermatol 1994: 31: S51-5.
12. Hester C, Hauman J, Thompson I, Theunissen F, Wolfaardt P. Oral carriage of candida in healthy and HIV-seropositive persons. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1993: 76: 570-2.
13. Holmstrup P, Axell T. Classification and clinical manifestations of oral yeast infections. Acta Odontol Scand 1990: 48: 57-9.
14. Holt RJ, Azmi A. Miconazole-resistant Candida. Lancet 1978: 1: 50-1.
15. Johnson EM, Warnock DW, Luker J, Porter SR, Scully C. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J Antimicrob Chemother 1995: 35: 103-14
16. Law D, Moore CB, Wardle HM, Ganguli LA, Keaney MG, Denning DW. High prevalence of antifungal resistance in Candida spp. from patients with AIDS. J Antimicrob Chemother 1994: 34: 659-68.
17. Nierebinska E, Gwiezdzinski Z, Urbanowski S, Pracz M. The increase of yeast-like fungi resistance to nystatine. Wiad Lek 1992: 45: 427-9.
18. Peterson E. Oral candidiasis. Clin Geriatr Med 1992: 8: 513-27.
19. Pfaller MA, Grant C, Porthland V, Thine-Chalberg J. Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans J Clin Microbiol 1994: 32: 506-9.
20. Rindum JL, Holmstrup P, Pedersen M, Rassing MR, Stoltze K. Miconazole chewing gum for treatment of chronic oral candidosis. Scand J Dent Res 1993: 101: 386-90
21. Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann M. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol 1994: 32: 2092-8.
22. Sandven P, Bjorneklett A, Maeland A. Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian study group. Antimicrob Agents Chemother 1993: 37: 2443-8